Related references
Note: Only part of the references are listed.Hypertension Induces Brain β-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature
Daniela Carnevale et al.
HYPERTENSION (2012)
Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in a mouse model of Alzheimer's disease
Tomoko Kurata et al.
NEUROLOGICAL RESEARCH (2012)
Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice
Tomoko Kurata et al.
BRAIN RESEARCH (2011)
Neurovascular Coupling in Cognitive Impairment Associated With Diabetes Mellitus
Masaki Mogi et al.
CIRCULATION JOURNAL (2011)
Telmisartan, a partial agonist of peroxisome proliferator-activated receptor γ, improves impairment of spatial memory and hippocampal apoptosis in rats treated with repeated cerebral ischemia
Tamami Haraguchi et al.
BRAIN RESEARCH (2010)
Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients
Akiko Aoki et al.
HEART AND VESSELS (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Candesartan improves memory decline in mice: Involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin
Santoshkumar Tota et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy
Norbert Zilka et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy
Miroslava Korenov et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
An Adipose Tissue-Independent Insulin-Sensitizing Action of Telmisartan: a Study in Lipodystrophic Mice
X. Rong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Protective effects of angiotensin II Type I receptor blocker on cerebral circulation independent of blood pressure
Yasuhiro Kumai et al.
EXPERIMENTAL NEUROLOGY (2008)
Candesartan and cognitive decline in older patients with hypertension - A substudy of the SCOPE trial
B. K. Saxby et al.
NEUROLOGY (2008)
Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment
Ivy O. Poon
PHARMACOTHERAPY (2008)
Prestroke cognitive performance, incident stroke, and risk of dementia - The Rotterdam Study
Christiane Reitz et al.
STROKE (2008)
Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease
Jun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Atrial fibrillation, stroke, and cognition -: A longitudinal population-based study of people aged 85 and older
Sari Rastas et al.
STROKE (2007)
Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
Patrick G. Kehoe et al.
LANCET NEUROLOGY (2007)
Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice
Kana Araki et al.
HYPERTENSION (2006)
Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo
Norbert Zilka et al.
FEBS LETTERS (2006)
Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis
K Sugimoto et al.
HYPERTENSION (2006)
Vascular risk factors for incident Alzheimer disease and vascular dementia - The Cache County study
Kathleen M. Hayden et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Update on hypertension and Alzheimer's disease
Ingmar Skoog et al.
NEUROLOGICAL RESEARCH (2006)
Effect of AT(1) receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappa B/I kappa B system
D Sanz-Rosa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study
G Derosa et al.
HYPERTENSION RESEARCH (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Preservation of cognitive function with antihypertensive medications
MD Murray et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
In vitro and in vivo characterization of the activity of telmisartan: An insurmountable angiotensin II receptor antagonist
MP Maillard et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia?
M Sabbatini et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2002)
Share Paper
